FDA Inspection 1249660 — Colorado Center for Reproductive Medicine-Atlanta

Colorado Center for Reproductive Medicine-Atlanta — FEI 3004432442

The FDA completed an inspection of Colorado Center for Reproductive Medicine-Atlanta on September 4, 2024 in Atlanta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 4, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Atlanta, GA (United States)